Treatment of bone defects generally requires a fixation device. Biodegradable implants can often prevent second operations in contrast to metallic implants that are surgically removed after healing. In this study, we investigate the preparation of a bone fixation device with additional bioactivity by adding nanoparticulate amorphous tricalcium phosphate (ATCP) to improve bonding to bone. Medically approved poly(lactide-co-glycolide) (PLGA) and spherical (ATCP) nanoparticles were blended directly or through a two-step approach, where ATCP was first dispersed in PLGA by solvent casting, extruded and hot pressed producing blocks and bone screws. The latter route yielded good particle dispersion while blending alone led to inhomogeneous mixtures. Samples were immersed in simulated body fluid and showed rapid formation of surface hydroxyapatite layers (examined by X-ray diffraction and scanning electron microscopy) already after 3 days, thus confirming very high bioactivity. Polymer degradation during processing and upon simulated implantation conditions was followed by gel permeation chromatography. The elevated temperature during extrusion was the strongest single factor contributing to PLGA degradation. Screws could be machined out of extruded cylinders and demonstrated the ability to process PLGA/ATCP 90/10 composites with regular workshop tools. These properties suggest the use of such composites as improved, bioactive, and degradable bone fixation systems particularly in oral and maxillofacial surgery. POLYM. ENG. SCI., 50:952-960, 2010. (C) 
INTRODUCTION
Biomedical composites are used in temporal or permanent implant materials and they have gained significant clinical interest due to their ability to integrate into the body [1] [2] [3] . The advantage of resorbable implants over metals lies in preventing subsequent operation for implant removal and reducing postoperative stress.
Biodegradable materials are currently used in clinical applications as sutures or as orthopedic fixation devices i.e. screws or plates [1, [4] [5] [6] in oral and maxillofacial surgery [7] . Poly(lactide-co-glycolide) (PLGA) is one of the most often used biodegradable synthetic polymers [8] . PLGA is known for its biocompatibility [9, 10] , the capability to support drug delivery [11] , nerve regeneration [12] and its commercial use in bone surgery [8] . With ongoing degradation, the polymer undergoes several alterations which result in molecular weight loss, structural changes and reduction in strength and stiffness. The latter is appropriate for bone fracture fixation systems as the implant should only initially provide mechanical support.
Polymer degradation successively reduces the mechanical performance and leads to a step by step transfer of load to the healing bone [1] . A potential drawback of degradation is the release of acidic degradation products that can lead to an inflammatory tissue response [13] .
Biodegradable polymers by themselves are not bioactive and therefore, they can not actively bind to bone. One strategy to overcome the lack of biological attachment to bone of biodegradable polymers is to combine the advantages of polymers and an inorganic bioreactive phase, i.e. through addition of bioreactive fillers that render the polymer bioactive (bonding to bone-tissue through formation of hydroxyapatite structures on the polymer surface) [14] . Among possible bioreactive fillers for biodegradable polymers, calcium phosphates or bioactive glasses represent a common choice because they can induce rapid and strong bonding of the composite to bone [15] [16] [17] . Calcium phosphates are commercially available and widely used for their excellent biocompatibility and osteoconductivity [18] . Amorphous tricalcium phosphate (ATCP) has been reported as an exceptionally reactive precursor for the formation of hydroxyapatite [19, 20] .
As an additional benefit, inorganic fillers can counteract and accordingly buffer the acidic degradation of some biopolymers, e.g. polylactides and polyglycolides, which otherwise cause inflammatory tissue response. Stabilization of pH around an implant is of particular interest [14] and has been demonstrated by the addition of alkaline compounds, for example calcium phosphates [16, 21] or bioactive glasses [22, 23] . Lin et al. [24] have shown that microsized and crystalline tricalcium phosphate (TCP) with low surface area used as filler in poly(α-hydroxy acids) resulted in decelerated degradation of the polymer and induced adverse mechanical properties during degradation [16] . A possibility to overcome this limitation can be the reduction of the filler particle size [25] to achieve enhanced dispersion and improved mode of action of tricalcium phosphate filler. Most recently, a significant improvement of bioactivity, degradation and mechanical properties of PLGA composites has been demonstrated by using nanosized instead of microsized ATCP fillers [26] . The induced nanostructured surface topography mimics the structure of natural bone, and resulted in higher protein adsorption [27] , increased osteoblast function [28, 29] and an improved implant-tissue interaction [30] . It would therefore be of high clinical interest to apply the exceptional bioactivity of ATCP nanofillers in currently used plate/screw bone fixation devices.
The study described in this paper investigates the production of PLGA/spherical-ATCP nanocomposite components with defined shape for orthopedic surgery. The study has been particularly motivated by recent observations on the improved bioactivity and controlled degradation of solvent-cast films (thickness: 120-150 µm) of PLGA and spherical ATCP nanoparticles [26] . We used a combined dispersion and blending approach and produced for the first time polymer/ATCP nanoparticles composites via solvent casting and solid blocks by extrusion and hot pressing. The degradation process during the different processing steps was monitored by gel permeation chromatography. A high apatite mineralization on this bulk composite was confirmed by a short term in vitro bioactivity study.
EXPERIMENTAL

Preparation of amorphous tricalcium phosphate nanoparticles
Amorphous tricalcium phosphate nanoparticles were prepared by flame spray synthesis [31] as described by Loher et al. [32] . Briefly, calcium hydroxide (Riedel de Haen, Ph. Eur.) dissolved in 2-ethylhexanoic acid (Sigma-Aldrich) and tributyl phosphate (98%, Sigma Aldrich) were used as precursors. The liquid precursormixture was diluted with xylene to a final metal concentration of 0.8 mol l -1 and pumped (9 ml min -1 ) through a capillary (diameter 0.4 mm), dispersed with oxygen (9 l min -1 ) and ignited by a methane/oxygen flame. The as-formed ATCP particles (production rate of 50 g h -1 ) were collected on bag-house filters and subsequently sieved (250 µm mesh). 
Production of ATCP/PLGA composite
Characterization of ATCP particles and PLGA/ATCP composites
The specific surface area (SSA) of ATCP particles was measured by nitrogen adsorption at 77 K according to the Brunauer-Emmett-Teller (BET) method using a Tristar 3000 (Micrometrics, Norcross, GA, USA) after out-gassing at 150 °C for 1 h.
The primary particle diameter assuming spherical particles was calculated according 
Processing and in vitro degradation
Degradation of neat PLGA and PLGA/ATCP composite was investigated during processing of the materials. Gel permeation chromatography (GPC) (Agilent 1100 Series, 2 x Mixed-C, Polymer Lab, flow rate 1 ml/min, calibrated with polystyrene) using tetrahydrofurane (THF) as eluting solvent was performed to determine the reduction of molecular weight starting from the raw material (PLGA) until the final product, i.e. the composite block. Furthermore, the degradation of PLGA/ATCP (90/10) was monitored regarding its residence time in the extruder.
A short term in vitro bioactivity study was performed using simulated body fluid (SBF) according to Kokubo et al. [35] . Freshly prepared SBF was sterile filtrated through a Nalgene ® pre-sterilized filter unit. Prior to GPC, all samples were dissolved in THF and the particle containing blocks were centrifuged. The supernatant was collected and examined by GPC. were homogenously dispersed in PLGA and also exposed at the surface (Figure 3a) .
RESULTS
Spherical
After hot pressing, however, the particles were well embedded in the polymer matrix (Figure 3b) . Reference experiments were made with dry mixtures of ATCP particles and PLGA granulates directly subjected to extrusion (no pre-dispersion or solvent casting step). These materials suffered from phase separation and did not become homogenous even after longer processing.
The in vitro bioactivity of composite blocks containing ATCP nanoparticles was confirmed by the distinct pattern of hydroxyapatite (HA) in the X-ray diffractogram (XRD) at 31.8° (Figure 4 ). In contrast, pure PLGA showed no HA formation, assessed by SEM, in agreement with earlier studies [38] (Figure 5c ).
However, the surface of PLGA after extrusion, hot pressing and immersion in SBF up Knowledge of polymer degradation is essential for optimizing processing conditions and for the final application as biomedical product. The number average molecular weight and weight average molecular weight decreased with increasing processing steps (Figure 7c ). Both the number of processing steps and the duration of extrusion had an influence on the degree of degradation (Figure 7d ) and underline the importance of pre-dispersion to keep extrusion times at an acceptable level.
DISCUSSION
Poly-lactides, -glycolides and their copolymers are widely used in orthopedics, for example for sutures [8] A distinct advantage of using reactive ATCP nanoparticles is their enhanced solubility compared to crystalline phases of TCP that show little or no reactivity [42] .
Nanosized ATCP reacts with water and enforces HA formation during recrystallization, according to: The spherical nanoparticles are virtually un-agglomerated (see particle size data), which facilitates their incorporation in a polymer and further processing of the composite if compared to much larger, crystalline, microsized α-and β-TCP [43] .
This enabled the preparation of composite pellets by twin screw extrusion with up to 30 wt% inorganic filler. While direct blending resulted in phase separation, solvent casting as a pre-dispersion step allowed rapid and homogeneous dispersion [44] ( Figure 3 ). Whilst longer residence times in an extruder might improve dispersion after direct blending, the degradation of polylactides at high temperatures [45, 46] disfavors such a strategy and highlights the need for a two-step preparation approach.
Bioactivity and surface changes
Neat PLGA pellets showed a smooth surface when compared to PLGA blocks directly after hot pressing ( Figure 5 ). This minor roughness was caused by the moulds. In the case of the composites, the nanoparticles induced a certain surface roughness, reflecting altered stress relaxation and adhesion to machine walls. After degradation in SBF, pure PLGA exhibited small holes in the surface which were a result of the elution of water soluble surfactant Tween20 [38] (Figure 5c ). The otherwise smooth surface supported no HA formation which was further confirmed by the absence of reflections in the XRD pattern even after 28 days in SBF (Figure 4 ). In contrast, both XRD and scanning electron microscopy (SEM) analysis confirmed the formation of HA crystals already after 3 days immersion in SBF for PLGA/ATCP 70/30 composites. The surface change revealed the rapid formation of nanosized HA on the composite surfaces (Figure 6b and 6c) . The fact that HA deposition occurred only on samples containing ATCP nanoparticles underlined the importance of ATCP as a reaction and nucleation site for HA formation [47, 48] . The broad diffraction signal resembles the nanosized and poorly crystalline HA in natural bone mineral [49] . Larger HA deposits were observed after 28 days of immersion in SBF, which entirely covered the surface of degraded composite blocks (Figure 6d ).
Composite degradation
Two competing processes can alter the surface structure and composition of a bioactive composite. Polymer degradation and dissolution of calcium phosphate contributes to mass loss. In addition, it must be pointed out that ATCP nanoparticles first dissolve and then re-crystallize either on the composite's surface (overall mass increases; see Figure 7b ) or separately (the composite material loses mass and mineral deposits on the walls and bottom of the test container are found). The complexity of this mechanism is best illustrated using the (apparently contradicting) mass changes for composites with 10 and 30 wt% filler (Figure 7b ). Mineralization is presumably switching between predominantly "separately" to "on the material's surface". The latter deposition of HA crystals obviously contribute to a mass increase (i.e. sample 90/10). The mineral deposition on the surfaces of the biomaterial is a marker for in vitro bioactivity and enables the surrounding tissue to bind strongly to the implant material. The overall mass change can be used as an indicative measure for the combined action of polymer degradation and/or HA deposition and water uptake (swelling). Porosity was monitored for all composite samples during in vitro degradation in SBF up to 28 days (Figure 7a and 7b) by measuring the mass difference between wet and dry samples (water trapped in pores). For neat PLGA, hardly any mass change could be detected during 28 days, although the water absorption increased with prolonged immersion in SBF. The increased water absorption is due to the hydrophilic character of PLGA and its degradation products [50] . This is in agreement with little changes in surface topography and few polymer degradation. Adding ATCP nanoparticles as a filler resulted in a higher water absorption ( Figure 7a ) as a result of pore formation (dissolved filler particles leave pores in the material) and enhanced swelling of composite blocks (pores allow water to penetrate farther into the material). Loher et al. [26] have shown that water uptake did not increase for dense, pure, solvent cast PLGA films with a thickness of 120-150
µm. In the present study, hot pressed blocks with a thickness of 1.6 mm were used.
Pressed, granulate derived, pure PLGA is apparently porous enough to allow some water uptake during prolonged immersion. This observation is further supported by the findings of Ehrenfried et al. [50] who described a mechanism based on water absorption and on the actual polymer degradation in relation to different α-TCP quantities. The water content describes the balance between hydrated oligomers going into the solution and the water uptake to the residual mass [50] meaning that not only pore formation but also the accumulation of hydrolytic degradation products is responsible for the increasing water uptake of PLGA/ATCP 90/10 composites. The water uptake of PLGA/ATCP 70/30 composites reached a plateau which is similar to a most recent study [50] . Furthermore not only the water absorption but also the onset of mass loss can be shifted for higher calcium phosphate loadings. However, the here described polymer loss is lower due to the different copolymer ratio of 85:15 if compared to the 50:50 ratio in the study by Ehrenfried et al. [50] where one of the fastest degrading copolymer ratios of PLGA was used [8] .
Polymer degradation during processing
GPC revealed that the highest reduction in molecular weight occured during the processing steps when heat was applied: extrusion and hot pressing (Figure 7c and   7d ). This result is in agreement with the fact that PLGA degradation can be mainly attributed to the duration and heat exposure during material processing [51] . The extrusion time should therefore be kept as short as possible. Moisture and shear stress can additionally contribute to degradation and thereby affect the final mechanical properties [52] . As no stabilizers are allowed for implant materials (FDA guidelines), the processing parameters have to be controlled carefully to obtain the desired product properties. Since polymer degradation is both affected by mass transfer (availability of water) and thermodynamics (reaction kinetics of the polymer), the addition of an inorganic fillers has been reported to reduce both degradation rates in vitro [53, 54] or accelerate degradation through facilitated pore formation [26] . The present work uses a highly reactive filler; hence, degradation is likely to be accelerated through facilitated pore formation and faster water absorption.
CONCLUSION
The present study has enabled the combination of high bioactivity with easy processing for specific biodegradable bone implant devices based on PLGA and 
